Učitavanje...
Dantrolene : From Malignant Hyperthermia to Alzheimer’s Disease
BACKGROUND & OBJECTIVE: Dantrolene, a ryanodine receptor antagonist, is primarily known as the only clinically acceptable and effective treatment for malignant hyperthermia (MH). Inhibition of ryanodine receptor (RyR) by dantrolene decreases the abnormal calcium release from the sarcoplasmic ret...
Spremljeno u:
| Izdano u: | CNS Neurol Disord Drug Targets |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754833/ https://ncbi.nlm.nih.gov/pubmed/29921212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871527317666180619162649 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|